Centre Hospitalier Jacques Coeur
- Address
- lock Available on a paid plan
Respiratory Tract Diseases and Critical Care
At Centre Hospitalier Jacques Coeur in Bourges, clinical research in respiratory medicine and intensive care focuses on patients with de novo acute respiratory failure and related support needs. The trials are designed to evaluate ways to improve breathing support and help patients recover more effectively in the ICU.
- Improving the success of High-Flow Nasal Oxygen Therapy weaning in critically ill patients
- Assessing strategies that support better management of acute respiratory failure
- Testing practical approaches to optimize oxygen therapy in intensive care
This area of research aims to strengthen treatment effectiveness and support safer, more efficient care for patients with serious breathing problems.
Nervous System Diseases and Delirium
The site also studies neurological complications commonly seen in critical care, especially delirium. Research here explores whether changing sedation practices can reduce confusion and improve patient outcomes during invasive ventilation and emergency care.
- Comparing inhaled sedation with standard intravenous sedation
- Evaluating the effect of sedation choices on delirium occurrence
- Supporting safer and more comfortable care for intensive care patients
These studies focus on improving symptom control and lowering the risk of mental status changes in critically ill patients.
Hemic and Lymphatic Diseases and Bacterial Infections
Clinical trials at Centre Hospitalier Jacques Coeur also address haematological disorders in adult patients receiving chemotherapy, where infection-related fever and neutropenia are important concerns. The research examines outpatient antibiotic treatment options to help manage these high-risk episodes more effectively.
- Studying treatment for chemotherapy-induced fever in adult haematology patients
- Evaluating antibiotic approaches for febrile neutropenia
- Testing whether a simpler oral regimen can perform as well as a broader reference treatment
This work is aimed at improving infection management, supporting outpatient care, and maintaining effective treatment for patients with blood-related diseases.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Centre Hospitalier De Versailles1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centre Hospitalier Jacques Coeur
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Comparative Efficacy of Amoxicillin-Clavulanic Acid Versus Amoxicillin-Clavulanic Acid Plus Ciprofloxacin in Chemotherapy-Induced Fever in Adult Hematology Patients | Centre Hospitalier De Versailles | Phase III | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 5 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Amoxicillin Sodium | 1 | Unknown | — | — |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.